Filippo D’Amico
banner
filippodamico.bsky.social
Filippo D’Amico
@filippodamico.bsky.social
Anesthesia and Intensive care San Raffaele Hospital
Solo 3 RCT sugli aminoacidi, ma uno aveva 3.511 pazienti. Contare i trial non misura la forza dell’evidenza. Tutti e tre: meno AKI.
https://authors.elsevier.com/a/1nwI23lSIQ3d2Y
October 12, 2026 at 6:31 PM
Only 3 amino-acid RCTs—but one enrolled 3,511 patients. Trial count is not evidence strength. All three showed numerically less AKI.
https://authors.elsevier.com/a/1nwI23lSIQ3d2Y
October 12, 2026 at 5:02 PM
207 RCT sembrano definitivi. Trial mediano: 120 pazienti; 77% monocentrico; la maggior parte neutra. Più studi ≠ più certezza.
https://authors.elsevier.com/a/1nwI23lSIQ3d2Y
October 12, 2026 at 1:31 PM
207 RCTs sound definitive. Median trial: 120 patients; 77% single-centre; most neutral. More studies ≠ more certainty.
https://authors.elsevier.com/a/1nwI23lSIQ3d2Y
October 12, 2026 at 12:03 PM
Nuovo lavoro: 207 RCT, 55 interventi, ~64mila pazienti. Abbiamo mappato l’evidenza randomizzata per prevenire AKI dopo cardiochirurgia.
https://authors.elsevier.com/a/1nwI23lSIQ3d2Y
October 12, 2026 at 8:31 AM
New paper: 207 RCTs, 55 interventions, ~64k patients. We mapped randomized evidence to prevent AKI after cardiac surgery.
https://authors.elsevier.com/a/1nwI23lSIQ3d2Y
October 12, 2026 at 7:02 AM
CENSER viene ricordato come il trial della noradrenalina precoce. Più utile oggi: entrambi i gruppi miravano a PAM ≥65; cambiava quando il supporto vasoattivo entrava nella rianimazione. Stesso target, sequenza diversa. Il timing è parte della strategia. #ProtectiveHemodynamics
https://doi.org/10.11
DOI Name 10.11 Values
doi.org
September 24, 2026 at 6:31 PM
CENSER is often remembered as an early-norepinephrine trial. More useful today: both groups aimed for MAP ≥65; what changed was when vasoactive support entered resuscitation. Same target, different sequence. Timing is part of hemodynamic strategy. #ProtectiveHemodynamics
https://doi.org/10.1164/rccm
Error: DOI Not Found
doi.org
September 24, 2026 at 5:01 PM
La parte interessante non è l’“AI”. Era un percorso deterministico basato su regole + revisione del medico: concordanza ASA non inferiore e tempo 6→2 min, ma peggiore comprensione dei rischi. Automatizzare i dati non significa migliorare la conversazione. #Anesthesia
https://doi.org/10.1186/s12871-0
Error: DOI Not Found
doi.org
September 24, 2026 at 1:31 PM
The interesting part is not “AI.” This was a deterministic rule-based workflow plus resident review: ASA concordance was noninferior and assessment time fell 6→2 min, yet risk understanding worsened. Automation can standardize data without improving conversation. #Anesthesia
https://doi.org/10.1186/
Error: DOI Not Found
doi.org
September 24, 2026 at 12:03 PM
Il punto non è sostituire la PAM con un target microcircolatorio. È smettere di chiedere a una sola variabile di certificare la perfusione: pressione, flusso e segnali tissutali possono divergere. La coerenza emodinamica va verificata, non presunta. #ProtectiveHemodynamics
https://doi.org/10.1186/s1
Error: DOI Not Found
doi.org
September 24, 2026 at 8:31 AM
The point is not to replace MAP with a microcirculatory target. It is to stop asking one variable to certify perfusion: pressure, flow and tissue signals can disagree. Hemodynamic coherence must be tested, not assumed. #ProtectiveHemodynamics
https://doi.org/10.1186/s13054-026-06353-7
Beyond macrocirculatory targets: a multimodal framework for microcirculatory and organ perfusion monitoring in sepsis - Critical Care
Background Microcirculatory dysfunction may persist despite restoration of conventional macrocirculatory targets in sepsis, reflecting loss of hemodynamic coherence. This review synthesizes current microcirculatory monitoring approaches according to the physiological information they provide and examines how complementary modalities may be integrated to characterize persistent or regional tissue hypoperfusion. Main body A narrative review of PubMed-indexed literature was conducted, with emphasis on bedside peripheral perfusion assessment, tissue oxygenation and superficial perfusion imaging, direct microvascular visualization, and organ- or tissue-specific monitoring. Recent studies were prioritized together with landmark methodological and validation studies. Available techniques interrogate distinct but overlapping components of the circulation. Bedside peripheral measures provide rapid information on skin reperfusion and vascular tone; spectroscopic and optical techniques characterize tissue oxygenation, reactivity, and spatial perfusion heterogeneity; direct microvascular imaging enables assessment of microvascular density and flow; and organ-specific approaches provide information on renal, cerebral, or retinal perfusion and oxygenation. Discordance between these domains may persist despite improvement in blood pressure or cardiac output, supporting serial multimodal rather than single-variable interpretation. However, substantial heterogeneity in acquisition protocols, measurement sites, devices, analytical methods, and proposed thresholds limits comparability and clinical implementation. Conclusion Microcirculatory monitoring should currently be viewed as a complementary framework for identifying persistent or heterogeneous tissue hypoperfusion beyond conventional macrocirculatory targets. Its integration into individualized resuscitation remains promising but requires standardized methodology, external validation, and prospective interventional evidence before any single modality or multimodal strategy can be adopted as a validated resuscitation endpoint.
doi.org
September 24, 2026 at 7:01 AM
EU Parliament calls for at least 1m more health workers by 2034. In ICU, staff are capacity. Can Europe fix its gap without worsening shortages in countries it recruits from? #HealthWorkforce
https://oeil.europarl.europa.eu/oeil/en/procedure-file?reference=2025/2062(INI)
oeil.europarl.europa.eu
September 23, 2026 at 4:15 PM
Un trial di prehabilitation del 2010 nasconde una lezione moderna: il “controllo” con cammino e respirazione superò cicloergometro/forza nel recupero del cammino postoperatorio. Complessità del programma ≠ efficacia; aderenza e comparatore possono contare di più. #Prehabilitation
https://doi.org/10.
Error: Not a DOI
doi.org
September 23, 2026 at 1:31 PM
A 2010 prehabilitation trial hid a modern lesson: the “control” of walking and breathing outperformed structured cycling/strengthening in postoperative walking recovery. Program complexity is not efficacy; adherence and comparator design may matter more. #Prehabilitation
https://doi.org/10.1002/bjs.
Error: DOI Not Found
doi.org
September 23, 2026 at 12:01 PM
In 133 pazienti ICU trattati con landiololo, l’intolleranza non era bradicardia: era ipotensione o aumento dei vasopressori, quasi sempre entro 6 h. Pressione diastolica bassa e vasopressori in corso possono segnalare scarsa riserva emodinamica. #Hemodynamics #CriticalCare
https://doi.org/10.1186/s1
Error: DOI Not Found
doi.org
September 23, 2026 at 8:30 AM
In 133 ICU patients given landiolol, intolerance was not bradycardia: it was hypotension or rising vasopressor need, usually within 6 h. Low diastolic pressure and vasopressor dependence may signal limited hemodynamic reserve. #Hemodynamics #CriticalCare
https://doi.org/10.1186/s13054-026-06342-w
Early hemodynamic tolerance of landiolol in critically ill patients with supraventricular arrhythmia: a retrospective cohort study - Critical Care
Background Supraventricular arrhythmias are frequent in critically ill patients and landiolol, an ultra-short-acting, highly β1-selective adrenergic blocker, is increasingly used for their management. Its efficacy and dosing have been described, but its early hemodynamic tolerance at the bedside — when intolerance occurs, how it presents, and which patients are at risk — remains poorly characterized, particularly in vasopressor-dependent patients under-represented in existing cohorts. We aimed to describe the hemodynamic tolerance of landiolol and to identify bedside predictors of poor tolerance. Methods We conducted a retrospective single-center study in patients admitted to the intensive care unit who received landiolol for supraventricular arrhythmia between January 2021 and February 2023. Hemodynamic variables, including pulse pressure, were recorded at baseline (H0) and at H1, H2, H4, H6 and H24. A hemodynamic adverse event was defined as a composite of mean arterial pressure below 64 mmHg, bradycardia below 50 bpm, or a more than 50% increase in vasopressor dose, counted only while landiolol was infused. Predictors of poor tolerance were identified by multivariable logistic regression. Results Among 133 patients (median age 68 years; SAPS II 51; sepsis 54.9%; vasopressors 49.6%), a hemodynamic adverse event occurred in 27 (20.3%), mostly within the first six hours. Events consisted of hypotension or vasopressor escalation; no patient developed bradycardia below 50 bpm. A lower diastolic pressure (adjusted OR 1.05 per 1-mmHg decrease, 95% CI 1.01–1.10) and vasopressor use at initiation (adjusted OR 3.00, 95% CI 1.14–7.91) were independently associated with poor tolerance. Heart rate control was achieved without deterioration of arterial pressure, pulse pressure, ventricular function, or tissue perfusion. Conversion to sinus rhythm was more frequent in new-onset than in pre-existing atrial fibrillation (54.4% vs. 27.9%; p = 0.004). Conclusion In critically ill patients, hemodynamic intolerance to landiolol occurred in one-fifth of cases, arose early, and took the form of hypotension or increased vasopressor requirements rather than bradycardia. A low diastolic pressure and vasopressor dependence identified patients at risk, supporting cautious, individualized use with close monitoring during early titration.
doi.org
September 23, 2026 at 7:31 AM
NZ has created a legal path for paramedic prescribing, but it is not operational yet. Is this mainly about gaps in medical access—or the normal evolution of healthcare? #Paramedicine
https://paramediccouncil.org.nz/PCNZ/PCNZ/1.Public-and-Employers/Prescribing-Authority.aspx
Prescribing Authority
paramediccouncil.org.nz
September 22, 2026 at 4:15 PM
ANDROMEDA-SHOCK va riletto dopo ANDROMEDA-SHOCK-2. L’idea chiave non era “CRT batte lattato”: un endpoint rapido può dirci quando smettere di aumentare fluidi e vasoattivi. La rianimazione ha bisogno di stopping rules, non solo target. #ProtectiveHemodynamics
https://doi.org/10.1001/jama.2019.0071
doi.org
September 22, 2026 at 1:31 PM
ANDROMEDA-SHOCK is worth rereading after ANDROMEDA-SHOCK-2. Its key idea was not “CRT beats lactate”: a fast endpoint can tell us when to stop escalating fluids and vasoactives. Resuscitation needs stopping rules, not only targets. #ProtectiveHemodynamics
https://doi.org/10.1001/jama.2019.0071
doi.org
September 22, 2026 at 12:01 PM
England will extend Martha’s Rule to every A&E: patients, families and staff can trigger an urgent review when deterioration concerns are not heard. Who should hold the power to bypass hierarchy? #PatientSafety
https://www.theguardian.com/society/2026/sep/22/marthas-rule-expanded-nhs-england
Martha’s rule to be expanded to every A&E in England
System gives patients, loved ones and health workers the right to ask for a second opinion on care
www.theguardian.com
September 22, 2026 at 11:15 AM
CHEM-FACT: a 30 min l’ossigenazione cerebrale media era simile, ma con fenilefrina il calo era del 9% maggiore vs efedrina mentre aumentava la domanda metabolica. Il segnale era nella traiettoria. #Hemodynamics #Anesthesia
https://doi.org/10.1097/ALN.0000000000006239
Cerebral Hemodynamic and Metabolic Responses to... : Anesthesiology
Background:Ephedrine has been suggested to improve cerebral microcirculation and perfusion compared with phenylephrine. However, prospective...
doi.org
September 22, 2026 at 8:31 AM
CHEM-FACT shows why averages can mislead: mean cerebral oxygenation at 30 min was similar, yet phenylephrine caused a 9% greater decline than ephedrine while metabolic demand rose. The trajectory carried the signal. #Hemodynamics #Anesthesia
https://doi.org/10.1097/ALN.0000000000006239
Cerebral Hemodynamic and Metabolic Responses to... : Anesthesiology
Background:Ephedrine has been suggested to improve cerebral microcirculation and perfusion compared with phenylephrine. However, prospective...
doi.org
September 22, 2026 at 7:01 AM
PRAEP-GO è enorme per la prehab: 1.382 pazienti fragili/pre-fragili in 19 ospedali. Tre settimane di prehab supervisionata non hanno ridotto la dipendenza assistenziale a 12 mesi. La fragilità da sola può non selezionare chi beneficia. #Prehabilitation
https://doi.org/10.1016/j.lanhl.2026.100899
Redirecting
doi.org
September 21, 2026 at 1:31 PM